Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 3, 2011, Pages 436-440

  Van Den Esschert, Jacomina W ^a   Bieze, Matthanja ^a   Beuers, Ulrich H ^a   Van Gulik, Thomas M ^a   Bennink, Roelof J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Benign liver neoplasms; Hepatology; Liver cell adenoma; Nuclear medicine

Indexed keywords

FLUOROCHOLINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL OBSERVATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; GOLD STANDARD; HEMIHEPATECTOMY; HEPATOCELLULAR ADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER ADENOMA; LIVER BIOPSY; LIVER FOCAL NODULAR HYPERPLASIA; LIVER PARENCHYMA; LIVER RESECTION; LIVER SURGERY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOMA, LIVER CELL; ADULT; BIOLOGICAL TRANSPORT; CHOLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79953736361     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1584-0     Document Type: Article

References (9)

1. van den Esschert JW, van Gulik TM, Phoa SS. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg 2010;27:46-55.
2. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236:166-77. (Pubitemid 40853309)
3. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991;173:426-31.
4. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994;129:712-7. (Pubitemid 24208713)
5. Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 2000;24:372-6. (Pubitemid 30117769)
6. Bumsel F, Huchet V, Arrive L, Wendum D, Paye F, Poupon R, et al. Positron emission tomography (PET/CT) using fluro-choline allows to differentiate between adenoma and focal nodular hyperplasia (abstract 437). Hepatology 2007;46(Suppl. 1):433A.
7. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa CA, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-8. (Pubitemid 47436120)
8. Sutinen E, Nurmi M, Roivainen A, Varpula M, Tolvanen T, Lehikoinen P, et al. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging 2004;31:317-24. (Pubitemid 38314074)
9. Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, Oyen R, et al. Characterization of focal liver lesions with SonoVueenhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009;15:3748-56.